@article{49e5d2eadb4249a88d13f4637ef9d459,
title = "Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study",
keywords = "LIVER METASTASES, COLON-CANCER, MUTATION, BEVACIZUMAB, KRAS, CHEMOTHERAPY, FOLFOXIRI, SURVIVAL, 3122 Cancers",
author = "Aki Uutela and Emerik Osterlund and P{\"a}ivi Halonen and Raija Kallio and Annika {\AA}lgars and Tapio Salminen and Annamarja Lamminm{\"a}ki and Leena-Maija Soveri and Raija Ristam{\"a}ki and Kaisa Lehtom{\"a}ki and Hanna Stedt and Eetu Heerv{\"a} and Timo Muhonen and Juha Kononen and Arno Nordin and Ali Ovissi and Soili Kyt{\"o}l{\"a} and Mauri Kein{\"a}nen and Jari Sundstr{\"o}m and Lasse Nieminen and M{\"a}kinen, {Markus J.} and Teijo Kuopio and Ari Ristim{\"a}ki and Helena Isoniemi and Pia Osterlund",
year = "2022",
month = sep,
day = "1",
doi = "10.1038/s41416-022-01858-8",
language = "English",
volume = "127",
pages = "686--694",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "4",
}